compound semaglutide ending Ban: FDA Ends Alternatives to Ozempic® FDA Announces End to Semaglutide

Saxenda is contraindicated (must not be used) in people with: A personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a genetic condition that increases the risk of certain hormone-related tumors Tell your doctor immediately if you notice a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath

Hemoglobin A1c levels tend to rise within weeks to months after discontinuation, returning toward pre-treatment values

Consuming a diet of protein shakes, bars, and these supposedly healthy processed foods instead of real food

Single vs Triple Receptor Activation Traditional GLP-1 medications target one receptor and produce meaningful results for many people